FLASH SALE: Subscribe For Just ₹̶2̶9̶9̶9̶ ₹699
After Acquiring Rival E-Pharmacy Chain Medlife, PharmEasy Now Plans $500 Million IPO At $3 Billion Valuation: Report
Soon Buy More Than Just Patanjali Chyawanprash: Baba Ramdev Indicates IPO Launch Within A Month